发明名称 Biguanide Compositions and Methods of Treating Metabolic Disorders
摘要 Provided herein are methods for treating certain conditions, including diabetes, obesity, and other metabolic diseases, disorders or conditions by administrating a composition comprising a biguanide or related heterocyclic compound, e.g., metformin. Also provided herein are biguanide or related heterocyclic compound compositions, and methods for the preparation thereof for use in the methods of the present invention. Also provided herein are compositions comprising metformin and salts thereof and methods of use.
申请公布号 US2014341986(A1) 申请公布日期 2014.11.20
申请号 US201414451323 申请日期 2014.08.04
申请人 Elcelyx Therapeutics, Inc. 发明人 Baron Alain D.;Fineman Mark S.;Beeley Nigel R.A.
分类号 C07C279/26;C07D251/18;C07D255/02;A61K31/155;A61K9/28;A61K9/20;C07D317/58;A61K31/343;C07D307/52;A61K31/341;C07D207/06;A61K31/40;C07D211/14;A61K31/4453;C07D207/34;C07D307/66;A61K31/4196;C07D401/04;A61K31/454;C07D405/12;C07D409/12;A61K31/53;C07D251/10;A61K31/55;A61K45/06;C07D249/14 主分类号 C07C279/26
代理机构 代理人
主权项 1. A composition comprising a biguanide or related heterocyclic compound of structural Formula I,wherein: R1, R2, R3, R4, R5, R6, and R7 are independently selected from: H, OH, O—Rx, wherein Rx is alkyl, cycloalkyl, alkylcycloalkyl, acyl, ester, thioester; optionally substituted alkyl; cycloalkyl; alkylcycloalkyl; heterocycloalkyl; alkylheterocycloalkyl; optionally substituted alkenyl; optionally substituted alkynyl; optionally substituted aryl; optionally substituted alkylary; optionally substituted heteroaryl; optionally substituted alkylheteroaryl; and or R6 and R7 may join to form a bond, together forming a ring including the nitrogen atoms to which they are attached; or R1 and R2 may together form a 3 to 8 membered heterocyclic ring, including the nitrogen atoms to which they are attached; or R4 and R5 may together form a ring selected from the group aziridine, pyrrolyl, imidazolyl, pyrazolyl, indolyl, indolinyl, pyrrolidinyl, piperazinyl and piperidyl, including the nitrogen atoms to which they are attached.wherein the composition is adapted to reduce the average bioavailability of the compound, release a therapeutically effective amount of the compound to one or more regions of the intestine of a subject, or a combination thereof.
地址 San Diego CA US